A CASE OF MILIARY TUBERCULOSIS DEVELOPMENT IN A PATIENT WITH BEKHTEREV’S DISEASE


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The paper describes a case of miliary pulmonary tuberculosis development in an infliximab-treated patient with ankylosing spondyloarthritis (Bekhterev's disease) in a high tuberculosis incidence area. Multislice spiral computed tomography and preventive antituberculosis treatment are recommended in all cases of therapy with tumor necrosis factor-α inhibitors irrespective of the results of skin and IGRA tests.

Full Text

Restricted Access

About the authors

T. Pyanzova

Kemerovo State Medical Academy

Email: tatyana_vezhnina@mail.ru
Candidate of Medical Sciences

M. Primkulova

Kemerovo Regional Clinical Tuberculosis Dispensary

N. Belousova

Kemerovo Regional Clinical Tuberculosis Dispensary

Candidate of Medical Sciences

S. Pankratova

Kemerovo Regional Hospital for War Veterans

Candidate of Medical Sciences

References

  1. Saraux A., Guides C., Allain J. et al. Prevalence of rheumatoid arthritis and sponduloarthropathy in Brittany, France. Societe de Reumatologir de l’Ouest. // J. Rheum. - 1999; 26: 2622-7.
  2. Каратеев Д.Е. Вопросы безопасности терапии ингибиторами ФНОа // Соврем. ревматология. - 2009; 3: 33-8.
  3. Мезенова Т.В., Тюрин В.П., Давидьян С.Ю. и др. Сравнительная эффективность инфликсимаба и адалимумаба у пациентов с анкилозирующим спондилитом // Научно-практ. ревматол. - 2012; 2: 25-30.
  4. Baraliakos X., Listing J., Brandt J. et al. Persistent clinical response to the anti TNF-α antibody infliximab in patients with ankylosing spondylitis over 3 years // Rheumatology. - 2005; 44: 670-6.
  5. Dixon W., Hyrich K., Watson K. et al. Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR) // Ann. Rheum. Dis. - 2010; 69 (3): 522-8.
  6. Tubach F., Salmon D., Ravaud P. et al. Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor tumor necrosis factor receptor therapy. The three-year prospective french research axed on tolerance of biotherapies registry // Arthr. Rheum. - 2009; 60 (7): 188494.
  7. Некрасов Е.В., Стрелис А.К., Янова Г.В. и др. Случай генерализованного туберкулеза на фоне приема препарата инфликсимаба (Ремикейд) у больного с болезнью Бехтерева // Туберкулез и болезни легких. - 2009; 8: 56-60.
  8. Краснов В.А., Чернышев В.М., Стрельченко О.В. и др. Факторы, препятствующие улучшению ситуации по туберкулезу в субъектах Сибирского Федерального округа // Туберкулез и болезни легких. - 2012; 10: 8-14.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2014 Russkiy Vrach Publishing House